Cargando…
Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
BACKGROUND: The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989225/ https://www.ncbi.nlm.nih.gov/pubmed/33796601 http://dx.doi.org/10.1093/ofid/ofab090 |
_version_ | 1783668912733290496 |
---|---|
author | Rodebaugh, Thomas L Frumkin, Madelyn R Reiersen, Angela M Lenze, Eric J Avidan, Michael S Miller, J Philip Piccirillo, Jay F Zorumski, Charles F Mattar, Caline |
author_facet | Rodebaugh, Thomas L Frumkin, Madelyn R Reiersen, Angela M Lenze, Eric J Avidan, Michael S Miller, J Philip Piccirillo, Jay F Zorumski, Charles F Mattar, Caline |
author_sort | Rodebaugh, Thomas L |
collection | PubMed |
description | BACKGROUND: The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration. METHODS: One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles. RESULTS: Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea. CONCLUSIONS: The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration. |
format | Online Article Text |
id | pubmed-7989225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79892252021-03-31 Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time Rodebaugh, Thomas L Frumkin, Madelyn R Reiersen, Angela M Lenze, Eric J Avidan, Michael S Miller, J Philip Piccirillo, Jay F Zorumski, Charles F Mattar, Caline Open Forum Infect Dis Major Articles BACKGROUND: The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration. METHODS: One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles. RESULTS: Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea. CONCLUSIONS: The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration. Oxford University Press 2021-03-01 /pmc/articles/PMC7989225/ /pubmed/33796601 http://dx.doi.org/10.1093/ofid/ofab090 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Articles Rodebaugh, Thomas L Frumkin, Madelyn R Reiersen, Angela M Lenze, Eric J Avidan, Michael S Miller, J Philip Piccirillo, Jay F Zorumski, Charles F Mattar, Caline Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time |
title | Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time |
title_full | Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time |
title_fullStr | Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time |
title_full_unstemmed | Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time |
title_short | Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time |
title_sort | acute symptoms of mild to moderate covid-19 are highly heterogeneous across individuals and over time |
topic | Major Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989225/ https://www.ncbi.nlm.nih.gov/pubmed/33796601 http://dx.doi.org/10.1093/ofid/ofab090 |
work_keys_str_mv | AT rodebaughthomasl acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT frumkinmadelynr acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT reiersenangelam acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT lenzeericj acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT avidanmichaels acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT millerjphilip acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT piccirillojayf acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT zorumskicharlesf acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime AT mattarcaline acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime |